Apotex and Olivieri

Patent lawyers are familiar with the name Apotex in a Hatch-Waxman context.

Another area concerns science fraud. From an abstract by Rhodes:

The Olivieri/Apotex affair is just another instance of academic medicine’s dereliction in a case of scientific fraud and misconduct. Instead of vigorously supporting their faculty member in her efforts to honestly communicate her findings and to protect patients from the risks associated with the use of the study drug, the University of Toronto collaborated with the Apotex company’s "stalling tactics," closed down Dr Olivieri’s laboratory, harassed her, and ultimately dismissed her.

Also:

http://ipbiz.blogspot.com/2008/11/sanofi-wins-over-apotex-in-plavix.html

http://ipbiz.blogspot.com/2008/08/cafc-hands-loss-to-apotex-impax-on.html

http://ipbiz.blogspot.com/2005/11/mondolino-leaves-morgan-lewis-for.html